NEW MJ NEWS

Cresco Labs Announces May Conference Participation

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced planned participation in upcoming conferences in May 2024.

19th Annual Needham Technology, Media & Consumer Conference, May 16, 2024, Virtual: Management will participate in a fireside chat and one-on-one meetings.

8th Annual Canaccord Global Cannabis Conference, May 23, 2024, New York City: Management will participate in panel and one-on-one meetings.

About Cresco Labs Inc.

Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs’ journey by visiting www.crescolabs.com or following the Company on Facebook, X or LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240509832021/en/

Contacts

Media
Jason Erkes, Chief Communications Officer
press@crescolabs.com
312-953-2767

Investors
investors@crescolabs.com

General Inquiries
312-929-0993
info@crescolabs.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tilray, Inc. (TLRY) Receives Approvals to Expand and Commercialize Medical Cannabis Products in New Zealand

Tilray® Receives Approvals to Expand and Commercialize Medical Cannabis Products in New…

Lifeist Wellness Inc. (NXTTF) CannMart Continues to Capture Market Share

Lifeist’s CannMart Continues to Capture Market Share, Generate Strong Sales for Roilty…

$SIPC Subsidiary Major Hemp Signs Hemp Beer Agreement

Sipp Industries Subsidiary Major Hemp Signs Hemp Beer Agreement With Ute Pass…

$LXRP To Commission Cannabinoid Education Series

Lexaria Commissions Cannabinoid Education Series Kelowna, BC / ACCESSWIRE / January 8,…